Results for hematologic malignancies

Add to feed Create your own feed

Latest

$EPZM #Epizyme  Inc ... Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended July 23: [...] #equity  #stocks 

tweet picture

@Soz86  @MelissaOctLibraN  @ABCot  a good strategy or analogy when kids <12 unvaccinated and many immunocompromised people - eg hematologic cancers, solid organ transplant on immunotherapy, other immunosuppressive meds for various non-CA diseases.

Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium#CCC19 ) Registry Analysis - @rubinstein_md  et al. @mtmdphd  @COVID19nCCC  #ASH20  Abstract 1632 n=167 MM , CFR 19% #mmsm  #IDonc  #COVID19nCancer 

tweet picture

Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd  & @DrJPHenderson  et al. @jwsenefeld  @DrDimpyShah  @hemoncwarner  @COVID19nCCC  - @JAMAOnc  #CCC19  #COVID19nCancer  #COVID19  #IDonc 

tweet picture

$EPZM #Epizyme  Inc ... Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended July 16: [...] #equity  #stocks 

tweet picture

Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium#CCC19 ) Registry Analysis - @rubinstein_md  et al. @mtmdphd  @COVID19nCCC  #ASH20  Abstract 1632 n=167 MM , CFR 19% #mmsm  #IDonc  #COVID19nCancer 

tweet picture

$CGEN: Compugen Doses First Patient in Phase 1 Combination Study of COM902 and COM701 in Patients with Advanced Malignancies

Antengene submits selinexor application in Taiwan in hematologic malignancies via SeekingAlpha #news  #SeekingAlpha 

Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd  & @DrJPHenderson  et al. @jwsenefeld  @DrDimpyShah  @hemoncwarner  @COVID19nCCC  - @JAMAOnc  #CCC19  #COVID19nCancer  #COVID19  #IDonc 

tweet picture

Loading
Loading

Most relevant

CD8 T cell responses to vaccination might provide protection in patients with hematologic cancer even in the setting of limited humoral responses, according to a study published in @NatureMedicine .

tweet picture

Tomorrow @ 7 AM PT, we are kicking off #ASH20  with a fireside chat between @StepahnieLeeMD  and Dr. Anthony Fauci on how #COVID19  has affected hematologic malignancies. #ASHCOVID  Log in to the platform early to be ready!

tweet picture

NIAID Director Dr. Anthony Fauci will join ASH President Dr. Stephanie Lee for a unique conversation on the pandemic's effects on hematologic conditions. Don’t miss it! Register now for the all-virtual ASH annual meeting.

Don’t miss NIAID Director Dr. Anthony Fauci and ASH President Dr. Stephanie Lee discuss the effects of the pandemic on hematologic conditions. Register for the all-virtual ASH annual meeting.

NIAID Director Dr. Anthony Fauci will join ASH President Dr. Stephanie Lee for a unique conversation on the pandemic's effects on hematologic conditions. Don’t miss it! Register now for the all-virtual ASH annual meeting.

Don’t miss NIAID Director Dr. Anthony Fauci and ASH President Dr. Stephanie Lee discuss the effects of the pandemic on hematologic conditions. Register for the all-virtual ASH annual meeting.

In adults with Ph–positive ALL, the use of ABL-specific TK inhibitors, with or without systemic chemotherapy, allows most patients to have a complete hematologic response; a sustained decrease in minimal residual disease is associated with an increased chance of cure.

“COVID-19 is not really just a respiratory infectious disease. In fact, there are really many hematologic complications of #COVID19  where our experience is required and really appreciated.” - @GhaithAZ90 ⁩ #ASHCOVID 

"It's hard to know exactly what an elective visit is," one doctor tells @ABC . "One of the ways that we find patients with malignancies is doing colonoscopies and upper endoscopies. A lot of them start off as elective procedures until you find the cancer."

Loading
Loading